Back to search results
NCT06262282

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

Enrolling by Invitation
Not specifiedAges 6+Observational
National Jewish Health
~10 participants
Updated 2025-05-21 on ClinicalTrials.gov
What's tested:mycobacteriophage

At a glance

Recruiting sites
0 of 18 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence to therapy
Measured over Comparing the year of phage therapy to the year prior to start of phage therapy

Conditions

Cystic Fibrosis
Nontuberculous Mycobacterial Lung Disease
Nontuberculous Mycobacterium Infection
Mycobacterium Infections
Mycobacterium; Pulmonary

Explore related trials

Atypical mycobacterial infection of lungCystic FibrosisMycobacteriophage

Where it's being run

18 sites across 16 states
California2
Colorado2
Alabama1
Florida1
Illinois1
Maryland1
Massachusetts1
Michigan1

Study leadership

  • Jerry Nick, MD · PRINCIPAL_INVESTIGATOR · National Jewish Health

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Adherence to therapyComparing the year of phage therapy to the year prior to start of phage therapy

    Proportion who adhere to the POSTSTAMP protocol based on number of respiratory cultures obtained per year, withdrawals or major deviations from protocol.